ClinicalTrials.Veeva

Menu

Registry and Biorepository for IBD in Central Texas

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Enrolling

Conditions

Ulcerative Colitis
Inflammatory Bowel Diseases
Crohn Disease

Treatments

Other: NO INTERVENTION

Study type

Observational

Funder types

Other

Identifiers

NCT04617184
2019-07-0137

Details and patient eligibility

About

This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters. The biorepository will consist of prospective collection of blood samples, tissue samples, and fecal samples for research purposes, while the participants are undergoing a clinically-indicated procedure (i.e. venipuncture for routine tests, IV catheter placement, and/or endoscopy). Participants may choose to provide any or all of the aforementioned information and/or samples.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female, age 18 years or older
  • Willing and able to provide written consent for participation in the registry and biorepository
  • Patients with known or suspected inflammatory bowel disease

Exclusion criteria

  • Patient is unable to comprehend and/or cooperate with study activities
  • Patient is too ill to provide consent
  • Coagulopathy that precludes safe biopsy of the bowel
  • Comorbidity that precludes safe participation in endoscopic procedures

Trial design

1,000 participants in 1 patient group

Inflammatory Bowel Disease
Description:
any patient with IBD will be included in the registry
Treatment:
Other: NO INTERVENTION

Trial contacts and locations

1

Loading...

Central trial contact

Benjamin Chebaa, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems